Literature DB >> 7756649

Reactive oxygen intermediates induce regulated secretion of von Willebrand factor from cultured human vascular endothelial cells.

U M Vischer1, L Jornot, C B Wollheim, J M Theler.   

Abstract

Exocytosis from Weibel-Palade bodies, the secretory granules of vascular endothelial cells, causes the rapid release of von Willebrand factor (vWF), an adhesive glycoprotein involved in primary hemostasis, and cell surface expression of P-selectin, a membrane protein involved in neutrophil binding. Thus, exocytosis may represent a link between hemostasis and inflammation. We investigated the effect of reactive oxygen intermediates (ROIs) on vWF secretion. Incubation of cultured endothelial cells with xanthine oxidase (XO), which generates superoxide anions (O2-), induces a potent, rapid secretory response. However, vWF release was not observed in response to H2O2. Extracellular, subendothelial vWF deposits typically seen after exocytosis from Weibel-Palade bodies were observed after exposure to XO. XO caused a rapid, sustained increase in intracellular free calcium concentration ([Ca2+]i). vWF secretion was markedly inhibited by BAPTA-AM, a cell-permeant calcium chelator. Removal of extracellular calcium did not inhibit vWF release, although the sustained phase of the [Ca2+]i increase was suppressed. These results suggest that XO-induced vWF release is mediated by the initial increase in [Ca2+]i which is caused by calcium mobilization from intracellular stores rather than by calcium influx. Exocytosis from Weibel-Palade bodies may contribute to the pathogenic effect of ROIs in atherosclerosis and inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7756649

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

1.  Transient Ca2+ changes in endothelial cells induced by low doses of reactive oxygen species: role of hydrogen peroxide.

Authors:  T Volk; M Hensel; W J Kox
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

Review 2.  Selectin-carbohydrate interactions during inflammation and metastasis.

Authors:  R P McEver
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

Review 3.  Platelets and von Willebrand factor in atherogenesis.

Authors:  Melinda D Wu; Tamara M Atkinson; Jonathan R Lindner
Journal:  Blood       Date:  2017-02-07       Impact factor: 22.113

4.  α-galactosidase A deficiency promotes von Willebrand factor secretion in models of Fabry disease.

Authors:  Justin J Kang; Nayiri M Kaissarian; Karl C Desch; Robert J Kelly; Liming Shu; Peter F Bodary; James A Shayman
Journal:  Kidney Int       Date:  2018-11-22       Impact factor: 10.612

Review 5.  Molecular and cellular biology of von Willebrand factor.

Authors:  Cécile V Denis
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

6.  Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis.

Authors:  Vural Taner Yilmaz; Dinc Dincer; Ali Berkant Avci; Ramazan Cetinkaya
Journal:  Eurasian J Med       Date:  2015-02

7.  Activation of naive xenogeneic but not allogeneic endothelial cells by human naive neutrophils: a potential occult barrier to xenotransplantation.

Authors:  F al-Mohanna; K Collison; R Parhar; A Kwaasi; B Meyer; S Saleh; S Allen; S al-Sedairy; D Stern; M Yacoub
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

8.  Fluvastatin inhibits regulated secretion of endothelial cell von Willebrand factor in response to diverse secretagogues.

Authors:  Richard J Fish; Hong Yang; Christelle Viglino; Raoul Schorer; Sylvie Dunoyer-Geindre; Egbert K O Kruithof
Journal:  Biochem J       Date:  2007-08-01       Impact factor: 3.857

9.  Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis.

Authors:  Janka Kisucka; Anil K Chauhan; Ian S Patten; Ayce Yesilaltay; Carola Neumann; Richard A Van Etten; Monty Krieger; Denisa D Wagner
Journal:  Circ Res       Date:  2008-08-08       Impact factor: 17.367

10.  Oxidative modification of von Willebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13.

Authors:  Junmei Chen; Xiaoyun Fu; Yi Wang; Minhua Ling; Brad McMullen; John Kulman; Dominic W Chung; José A López
Journal:  Blood       Date:  2009-10-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.